Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd)

Patrick J Hrdlicka; Jan S Jepsen; Jesper Wengel; Jan Stenvang

Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd)

Patrick J Hrdlicka, Jan S Jepsen, Jesper Wengel, Jan Stenvang

5 Citations (Scopus)

Abstract

A series of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd) and its uracil analog (EUrd) have been synthesized. While none of the conformationally restricted analogs displayed anticancer activity, 5-iodo-EUrd and 5-bromo-EUrd displayed potent anticancer activity with IC50 values of 35 nM and 0. 73 microM.

Original language	English
Journal	Nucleosides, nucleotides & nucleic acids
Volume	24
Issue number	5-7
Pages (from-to)	397-400
Number of pages	4
ISSN	1525-7770
Publication status	Published - 2005

Keywords

Antimetabolites
Antineoplastic Agents
Cell Line, Tumor
Chemistry, Pharmaceutical
Cytidine
Drug Design
Drug Screening Assays, Antitumor
Humans
Inhibitory Concentration 50
Models, Chemical
Neoplasms
Nucleic Acid Conformation
Uracil
Uridine

Cite this

Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd). / Hrdlicka, Patrick J; Jepsen, Jan S; Wengel, Jesper et al.

In: Nucleosides, nucleotides & nucleic acids, Vol. 24, No. 5-7, 2005, p. 397-400.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{bb2af42c11374852add8031b24cca327,

title = "Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd)",

abstract = "A series of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd) and its uracil analog (EUrd) have been synthesized. While none of the conformationally restricted analogs displayed anticancer activity, 5-iodo-EUrd and 5-bromo-EUrd displayed potent anticancer activity with IC50 values of 35 nM and 0. 73 microM.",

keywords = "Antimetabolites, Antineoplastic Agents, Cell Line, Tumor, Chemistry, Pharmaceutical, Cytidine, Drug Design, Drug Screening Assays, Antitumor, Humans, Inhibitory Concentration 50, Models, Chemical, Neoplasms, Nucleic Acid Conformation, Uracil, Uridine",

author = "Hrdlicka, {Patrick J} and Jepsen, {Jan S} and Jesper Wengel and Jan Stenvang",

year = "2005",

language = "English",

volume = "24",

pages = "397--400",

journal = "Nucleosides, Nucleotides and Nucleic Acids",

issn = "1525-7770",

publisher = "Taylor & Francis",

number = "5-7",

}

TY - JOUR

T1 - Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd)

AU - Hrdlicka, Patrick J

AU - Jepsen, Jan S

AU - Wengel, Jesper

AU - Stenvang, Jan

PY - 2005

Y1 - 2005

N2 - A series of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd) and its uracil analog (EUrd) have been synthesized. While none of the conformationally restricted analogs displayed anticancer activity, 5-iodo-EUrd and 5-bromo-EUrd displayed potent anticancer activity with IC50 values of 35 nM and 0. 73 microM.

AB - A series of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd) and its uracil analog (EUrd) have been synthesized. While none of the conformationally restricted analogs displayed anticancer activity, 5-iodo-EUrd and 5-bromo-EUrd displayed potent anticancer activity with IC50 values of 35 nM and 0. 73 microM.

KW - Antimetabolites

KW - Antineoplastic Agents

KW - Cell Line, Tumor

KW - Chemistry, Pharmaceutical

KW - Cytidine

KW - Drug Design

KW - Drug Screening Assays, Antitumor

KW - Humans

KW - Inhibitory Concentration 50

KW - Models, Chemical

KW - Neoplasms

KW - Nucleic Acid Conformation

KW - Uracil

KW - Uridine

M3 - Journal article

C2 - 16247958

SN - 1525-7770

VL - 24

SP - 397

EP - 400

JO - Nucleosides, Nucleotides and Nucleic Acids

JF - Nucleosides, Nucleotides and Nucleic Acids

IS - 5-7

ER -

Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd)

Abstract

Keywords

Fingerprint

Cite this